Laurion Capital Management’s AstraZeneca AZN Stock Holding History

Laurion Capital Management’s Portfolio AZN Stock Details AZN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-179,000	Closed	-$19.6M	–	419
2022 Q3	$19.6M	Sell	179,000 -15,250	-8%	-$1.93M	0.12%	142
2022 Q2	$25.7M	Buy	194,250 +138,000	+245%	+$18.1M	0.4%	58
2022 Q1	$7.46M	Buy	+56,250	New	+$6.75M	0.09%	135
2021 Q4	–	Sell	-60,000	Closed	-$7.21M	–	558
2021 Q3	$7.21M	Buy	+60,000	New	+$6.98M	0.03%	302
2017 Q3	–	Sell	-12,500	Closed	-$852K	–	1548
2017 Q2	$852K	Buy	+12,500	New	+$816K	﹤0.01%	1081
2015 Q1	–	Sell	-1,250,000	Closed	-$88M	–	336
2014 Q4	$88M	Buy	+1,250,000	New	+$89.5M	2.01%	13

Other funds holding AZN

Investor AB Stockholm, Sweden $15.1B AUM 29.02% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Legal & General Group London, United Kingdom $432B AUM 29.4% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

VAM

Vanguard Asset Management London, Ec4n 8af $117B AUM

Laurion Capital Management's AZN Position: Q1 2026 in Review

Laurion Capital Management held its AstraZeneca (AZN) position steady in Q1 2026 at 9,500 shares worth $1.87M. The position accounts for 0.08% of the portfolio, ranked #219.

Laurion Capital Management first reported a position in AZN in Q2 2017 and has held it in 10 quarters since. The position peaked at $23.9M in Q2 2017. 1,377 funds tracked by Wall St. Rank hold AZN as of Q1 2026.

Laurion Capital Management held 9,500 shares of AstraZeneca worth $1.87M as of Q1 2026.
Laurion Capital Management left its AstraZeneca share count unchanged in Q1 2026.
AstraZeneca made up 0.08% of Laurion Capital Management's portfolio in Q1 2026, its #219 holding.
Laurion Capital Management first reported a position in AstraZeneca in Q2 2017 and has held it in 10 quarters since.
Laurion Capital Management's AstraZeneca position peaked at $23.9M in Q2 2017.
1,377 funds tracked by Wall St. Rank held AstraZeneca as of Q1 2026.

Based on Laurion Capital Management's 13F filing for Q1 2026, filed 14 May 2026.